Search for a Clinical Trial

Stage/Subtype
No Options Available at this time
Trial Status / Phase
No Options for Trial Status / Phase available at this time
Protocol
Protocol Options not available
Age Range
Age Ranges not available
  • warning: rand() expects exactly 2 parameters, 1 given in /data01/site_data/floridahospitalcancer.com/sites/all/themes/fhci/page.tpl.php on line 17.
  • warning: rand() expects exactly 2 parameters, 1 given in /data01/site_data/floridahospitalcancer.com/sites/all/themes/fhci/page.tpl.php on line 20.
  1. Phase Type Status Age Protocol ID(s)
    II Treatment Closed 18+ GOG 130F

    Cancer Types

    Sarcoma, Uterine

    Description

    Purpose:

    Back to top
  2. Phase Type Status Age Protocol ID(s)
    II Treatment Closed 18+ GOG 0230D

    Cancer Types

    Sarcoma, Uterine

    Description

    Pazopanib hydrochloride may stop the growth of tumor

    Back to top
  3. Phase Type Status Age Protocol ID(s)
    II Treatment Active On-going 18+ PIM 4972g

    Cancer Types

    Endometrial Cancer

    Description

    This is a multicenter, single-arm, open-label Phase II study to evaluate the activity of GDC-0980 in patients with recurrent or persistent endometrial cancer. The safety, tolerability, and pharmacokinetics of GDC-0980 will also be evaluated.  

    Back to top
  4. Phase Type Status Age Protocol ID(s)
    II Treatment Closed <+ GOG 0254

    Cancer Types

    Ovarian Epithelial Cancer

    Description

    Back to top
  5. Phase Type Status Age Protocol ID(s)
    II Treatment Active On-going 18+ ECOG E2607

    Cancer Types

    Melanoma

    Description

    Back to top
  6. Phase Type Status Age Protocol ID(s)
    II Treatment Active On-going 18-65 SWOG S1106

    Cancer Types

    Lymphoma, Non-Hodgkin, Adult

    Description

    Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer-killing substances to them.

    Back to top
  7. Phase Type Status Age Protocol ID(s)
    II Treatment Active On-going 18+ CALGB 40603

    Cancer Types

    Breast Cancer

    Description

    Back to top
  8. Phase Type Status Age Protocol ID(s)
    II Treatment Active On-going 18+ BRE 186

    Cancer Types

    Breast Cancer

    Description

    The investigators propose to evaluate eribulin as adjuvant therapy in patients who do not achieve pCR following standard neoadjuvant chemotherapy. Three cohorts of patients will be evaluated separately: triple-negative, hormone-receptor-positive/HER2-negative, and HER2-positive.  

    Back to top
  9. Phase Type Status Age Protocol ID(s)
    II Treatment Approval Pending 60+ CALGB 11002

    Cancer Types

    Acute Myeloid Leukemia, Adult

    Description

    Back to top
  10. Phase Type Status Age Protocol ID(s)
    II Treatment Active On-going <+ Therakos 10-005

    Cancer Types

    Bone Marrow Transplant-Other

    Description

    The purpose of this study is to evaluate the safety and effectiveness of extracorporeal photopheresis therapy when added to standard drug therapies administered to patients with moderate to severe chronic graft-versus-host disease.  

    Back to top

Contact a Care Coordinator

ind Us - Map and Directions